Outcomes of tuberculosis combined with HIV infection

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Introduction. The epidemiological process in tuberculosis is negatively affected by the HIV epidemic, the identification of vulnerable groups in relation to the unfavorable course of tuberculosis in combination with HIV infection will improve approaches to treatment and prevention.

The aim of the study was to determine the outcomes of tuberculosis in HIV-infected patients under dispensary supervision with active tuberculosis, and the results of dispensary observation of clinically cured patients with co-infection.

Method. 187 patients aged 18–60 years with tuberculosis and HIV infection underwent clinical and laboratory, microbiological and radiation studies, statistical processing was carried out using the Microsoft Excel application software package.

Results. HIV-infected patients with clinical treatment of tuberculosis have low rates of CD4+ lymphocytes – (0,315•109±0,02)•109 and a high viral load compared to patients with active tuberculosis. After a year, 16.7% of patients with clinical treatment are removed from the register, 36.0% of patients with active tuberculosis are cured, 28.8% of patients have an exacerbation of the process or interruption of treatment, 11.3% die.

Conclusion. In HIV-infected patients with clinical treatment of tuberculosis, the indicators of CD4+ lymphocytes are lower and the viral load is higher than in patients with active tuberculosis, which indicates insufficient adherence to treatment at the outpatient stage and a high risk of recurrence of tuberculosis. The involvement of patients in working with the Call Center contributes to the formation of adherence to both anti-tuberculosis treatment and antiretroviral therapy and favorable outcomes of the disease.

Full Text

Restricted Access

About the authors

Elena Yu. Zorkaltseva

Irkutsk State Medical Academy of Postgraduate Education – Branch Campus of the Russian Medical Academy of Continuing Professional Education

Author for correspondence.
Email: zorkaltsewa@mail.ru
ORCID iD: 0000-0002-9449-7577

Medical Doctor, Professor, Head of the Department of tuberculosis and infection diseases

Russian Federation, Yubileyniy, 100, Irkutsk, 664079

Yulia O. Egorova

Irkutsk State Medical Academy of Postgraduate Education – Branch Campus of the Russian Medical Academy of Continuing Professional Education

Email: ya.yulia-e2013@yandex.ru
ORCID iD: 0000-0002-3117-0016

professors assistant Head of the Department of tuberculosis and infection diseases

Russian Federation, Yubileyniy, 100, Irkutsk, 664079

Yulia K. Plotnikova

Irkutsk State Medical Academy of Postgraduate Education – Branch Campus of the Russian Medical Academy of Continuing Professional Education

Email: plot18@yandex.ru
ORCID iD: 0000-0003-2912-9118

associate professor of the Department of tuberculosis and infection diseases

Russian Federation, Yubileyniy, 100, Irkutsk, 664079

Yulia V. Bazhenova

Irkutsk State Medical Academy of Postgraduate Education – Branch Campus of the Russian Medical Academy of Continuing Professional Education

Email: rg.dr@mail.ru
ORCID iD: 0000-0001-8939-3055

associate professor, Head of the Department of Radiation and Clinical Laboratory Diagnostics

Russian Federation, Yubileyniy, 100, Irkutsk, 664079

References

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Outcomes of tuberculosis and factors that negatively affect the effectiveness of treatment in patients of the I group of dispensary observation

Download (38KB)
3. Fig. 2. Results of dispensary observation of patients in group III

Download (35KB)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies